Pharmacopsychiatry · 1997 · 35 citations · 0 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyNeuropharmacologyPsychopharmacologyCardiac MedicationsOrthostatic HypotensionSerotonergic PharmacologyAdverse Cardiovascular Drug EventsCalcium Channel Blocker InteractionsCalcium Channel PharmacologyMedication-induced Orthostatic HypotensionNifedipine TherapySelective Serotonin Reuptake Inhibitor InteractionsSelective Serotonin Reuptake Inhibitor TreatmentSelective Serotonin Reuptake Inhibitor Use
The use of the selective serotonin reuptake inhibitor fluoxetine is associated with only minor cardiovascular effects. However, due to a possible inhibitory effect on the metabolism of calcium channel blockers it may potentiate the activity of nifedipine, causing profound adverse cardiovascular effects. This report describes the appearance of profound weakness, orthostatic hypotension and tachycardia following the initiation of fluoxetine treatment in a nifedipine-treated 80-year-old patient.